4gxv:L (LEU4) to (SER56) CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1 | IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM
2old:A (PCA1) to (SER58) BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(2)21 CRYSTAL FORM | IMMUNOGLOBULIN LIGHT CHAIN, IMMUNE SYSTEM
2omb:B (LEU4) to (PRO57) BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(1)21 CRYSTAL FORM | IMMUNOGLOBULIN LIGHT CHAIN, IMMUNE SYSTEM
2omb:D (LEU4) to (SER58) BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(1)21 CRYSTAL FORM | IMMUNOGLOBULIN LIGHT CHAIN, IMMUNE SYSTEM
2b0s:L (SER2) to (ARG50) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH MN PEPTIDE | FAB-PEPTIDE COMPLEX; HIV-1; GP120; V3 LOOP, IMMUNE SYSTEM
2b1a:L (SER2) to (LYS66) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE | FAB-PEPTIDE COMPLEX; HIV-1; GP120; V3 LOOP, IMMUNE SYSTEM
2b1h:L (SER2) to (SER67) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE | FAB-PEPTIDE COMPLEX; HIV-1; GP120; V3 LOOP, IMMUNE SYSTEM
4hem:E (GLN3) to (ARG61) LLAMA VHH-02 BINDER OF ORF49 (RBP) FROM LACTOCOCCAL PHAGE TP901-1 | ALPHA-BETA, PHAGE RECEPTOR BINDING PROTEIN, LLAMA VHH, VIRAL PROTEIN, CELL ADHESION-IMMUNE SYSTEM COMPLEX
4hpy:L (TYR2) to (SER56) CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH59 IN COMPLEX WITH V2 PEPTIDE | IMMUNOGLOBULIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3gbm:L (VAL3) to (SER56) CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ. | HEMAGGLUTININ, FAB, NEUTRALIZING ANTIBODIES, ANTIBODY, AVIAN FLU, ENVELOPE PROTEIN, FUSION PROTEIN, VIRAL PROTEIN - IMMUNE SYSTEM COMPLEX
4xvj:L (VAL4) to (SER57) STUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1 | ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
3ghb:L (LEU4) to (SER56) CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020 | HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE PROTEIN, IMMUNE SYSTEM
3ghb:M (VAL3) to (SER56) CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020 | HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE PROTEIN, IMMUNE SYSTEM
4j4p:L (VAL22) to (SER76) THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS | IG LIKE DOMAIN, IMMUNE SYSTEM
1q1j:L (LEU4) to (SER56) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE | FAB-PEPTIDE COMPLEX, HIV-1, GP120, V3 LOOP, IMMUNE SYSTEM
1q1j:M (LEU4) to (SER56) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE | FAB-PEPTIDE COMPLEX, HIV-1, GP120, V3 LOOP, IMMUNE SYSTEM
3tnm:B (LEU5) to (SER56) CRYSTAL STRUCTURE OF A32 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY | ADCC, NON-NEUTRALIZING, ANTI-HIV-1 ENV ANTIBODY A32, CD4I ANTIBODY, FAB, VIRAL GLYCOPROTEIN GP120, HIV-1 ENV, IMMUNE SYSTEM
3hae:L (LEU4) to (SER58) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3hae:S (GLN1) to (SER58) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1ucx:C (GLN15) to (ILE74) CRYSTAL STRUCTURE OF PROGLYCININ C12G MUTANT | PROGLYCININ, SOYBEAN, TRIMER, MUTANT, PLANT PROTEIN
1ud1:C (GLN15) to (ILE74) CRYSTAL STRUCTURE OF PROGLYCININ MUTANT C88S | GLYCININ, SOYBEAN, TRIMER, PLANT PROTEIN
4m1d:M (LEU4) to (SER56) CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN | HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE, IMMUNE SYSTEM
5alc:L (VAL3) to (SER56) TICAGRELOR ANTIDOTE CANDIDATE FAB 72 IN COMPLEX WITH TICAGRELOR | IMMUNE SYSTEM, ANTIBODY FRAGMENT, ANTIDOTE, DRUG
3wlw:L (GLN1) to (SER58) MOLECULAR ARCHITECTURE OF THE ERBB2 EXTRACELLULAR DOMAIN HOMODIMER | HYDROLASE-IMMUNE SYSTEM COMPLEX
1jaj:A (GLN25) to (TRP92) SOLUTION STRUCTURE OF DNA POLYMERASE X FROM THE AFRICAN SWINE FEVER VIRUS | CIS PEPTIDE, VIRAL PROTEIN
2j6e:L (VAL3) to (SER56) CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION | AUTOIMMUNE COMPLEX HUMAN IGM RHEUMATOID FACTOR IGG1-FC, IMMUNOGLOBULIN C REGION, MEMBRANE, GLYCOPROTEIN, TRANSMEMBRANE, HYPOTHETICAL PROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN
2j6e:M (VAL3) to (SER56) CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION | AUTOIMMUNE COMPLEX HUMAN IGM RHEUMATOID FACTOR IGG1-FC, IMMUNOGLOBULIN C REGION, MEMBRANE, GLYCOPROTEIN, TRANSMEMBRANE, HYPOTHETICAL PROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN
2m2u:A (GLN25) to (TRP92) BINARY COMPLEX OF AFRICAN SWINE FEVER VIRUS POL X WITH MGDGTP | DNA POLYMERASE, NUCLEOTIDYL TRANSFERASE, TRANSFERASE
1xed:A (PRO3) to (SER57) CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR, PIGR | IG-LIKE FOLD, IMMUNE SYSTEM
1xed:B (PRO3) to (SER57) CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR, PIGR | IG-LIKE FOLD, IMMUNE SYSTEM
1xed:C (PRO3) to (SER57) CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR, PIGR | IG-LIKE FOLD, IMMUNE SYSTEM
1xed:D (PRO3) to (SER57) CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR, PIGR | IG-LIKE FOLD, IMMUNE SYSTEM
4ocw:L (LEU4) to (SER56) CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.06, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY | FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM
4od1:L (VAL3) to (SER56) CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.03, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY | FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM
4od3:L (LEU4) to (SER56) CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.07, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY | FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM
4odh:L (SER2) to (SER56) CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.UCA, A POTENT V1V2- DIRECTED HIV-1 NEUTRALIZING ANTIBODY | FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM
5cus:L (SER2) to (SER57) CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX | ERBB3, ANTIBODY, TRANSFERASE
5cus:M (SER2) to (SER57) CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX | ERBB3, ANTIBODY, TRANSFERASE
5cus:O (SER2) to (SER57) CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX | ERBB3, ANTIBODY, TRANSFERASE
4org:L (VAL3) to (SER56) CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.04, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY | FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM
4org:B (LEU4) to (SER56) CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.04, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY | FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM
4org:D (VAL3) to (SER56) CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.04, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY | FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM
1mch:A (PRO1) to (SER58) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN
3ksc:A (GLU13) to (GLN74) CRYSTAL STRUCTURE OF PEA PROLEGUMIN, AN 11S SEED GLOBULIN FROM PISUM SATIVUM L. | PEA PROLEGUMIN, 11S SEED STORAGE PROTEIN, PISUM SATIVUM L., SEED STORAGE PROTEIN, STORAGE PROTEIN, PLANT PROTEIN
3lih:A (ALA493) to (ARG552) CRYSTAL STRUCTURE OF FRUCTOSYLTRANSFERASE (D191A) FROM A. JAPONICUS IN COMPLEX WITH RAFFINOSE | PROTEIN-OLIGOSACCHARIDE COMPLEX, FIVE BLADED BETA-PROPELLER FOLD, HYDROLASE
4aq1:B (VAL2) to (GLY61) STRUCTURE OF THE SBSB S-LAYER PROTEIN OF GEOBACILLUS STEAROTHERMOPHILUS PV72P2 IN COMPLEX WITH NANOBODY KB6 | STRUCTURAL PROTEIN, S-LAYER PROTEIN, NANOBODY
4aq1:D (GLN3) to (GLY61) STRUCTURE OF THE SBSB S-LAYER PROTEIN OF GEOBACILLUS STEAROTHERMOPHILUS PV72P2 IN COMPLEX WITH NANOBODY KB6 | STRUCTURAL PROTEIN, S-LAYER PROTEIN, NANOBODY
4q2z:B (LEU4) to (SER56) FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY, GE356, FROM A NON-HUMAN PRIMATE | FAB FRAGMENT, HIV VIRAL ENVELOPE GLYCOPROTEIN NEUTRALIZATION, IMMUNE SYSTEM
5dyo:A (VAL2) to (ASN61) FAB43.1 COMPLEX WITH FLOURESCEIN | ANTIBODY FAB FLOURESCEIN, IMMUNE SYSTEM
1zox:A (PRO3) to (ASN60) CLM-1 MOUSE MYELOID RECEPTOR EXTRACELLULAR DOMAIN | IG-SUPERFAMILY, IG-V, NKP44-LIKE, MYELOID IG-LIKE RECEPTOR, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, UNKNOWN FUNCTION
3lqa:L (SER3) to (SER58) CRYSTAL STRUCTURE OF CLADE C GP120 IN COMPLEX WITH SCD4 AND 21C FAB | COMPLEX, POLY REACTIVITY, IMMUNE SYSTEM
3lrh:C (LEU4) to (PRO57) STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN IN COMPLEX WITH HUNTINGTIN PEPTIDE | HUNTINGTON'S DISEASE, HUNTINGTIN, VARIABLE LIGHT CHAIN DOMAIN, INTRABODY, IMMUNOGLOBULIN, IMMUNE SYSTEM
3lrh:K (LEU4) to (PRO57) STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN IN COMPLEX WITH HUNTINGTIN PEPTIDE | HUNTINGTON'S DISEASE, HUNTINGTIN, VARIABLE LIGHT CHAIN DOMAIN, INTRABODY, IMMUNOGLOBULIN, IMMUNE SYSTEM
3lrh:O (VAL3) to (PRO57) STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN IN COMPLEX WITH HUNTINGTIN PEPTIDE | HUNTINGTON'S DISEASE, HUNTINGTIN, VARIABLE LIGHT CHAIN DOMAIN, INTRABODY, IMMUNOGLOBULIN, IMMUNE SYSTEM
3lrs:L (LEU4) to (SER55) STRUCTURE OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1 | NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM
4qf1:L (TYR2) to (SER56) CRYSTAL STRUCTURE OF UNLIGANDED CH59UA, THE INFERRED UNMUTATED ANCESTOR OF THE RV144 ANTI-HIV ANTIBODY LINEAGE PRODUCING CH59 | ANTI-HIV ANTIBODY, GP120, IMMUNE SYSTEM
4qf1:B (TYR2) to (SER56) CRYSTAL STRUCTURE OF UNLIGANDED CH59UA, THE INFERRED UNMUTATED ANCESTOR OF THE RV144 ANTI-HIV ANTIBODY LINEAGE PRODUCING CH59 | ANTI-HIV ANTIBODY, GP120, IMMUNE SYSTEM
3mls:L (TYR2) to (SER56) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, MIMOTOPE, IMMUNE SYSTEM
3mlu:L (TYR2) to (SER56) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A ZAM18 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mly:L (VAL3) to (SER56) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mly:M (LEU4) to (SER56) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mlz:L (VAL3) to (SER56) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A VI191 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
4bjl:B (LEU4) to (SER57) LOCW, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN DISTILLED WATER | BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES, IMMUNOGLOBULIN
5f6h:P (LEU4) to (SER58) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
3c2a:L (LEU4) to (SER56) ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE | ANTIBODY FAB HIV-1 PEPTIDE, ENVELOPE PROTEIN, IMMUNE SYSTEM
4rfe:B (VAL3) to (SER56) CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB | HIV-1 GP120 SPECIFIC ANTIBODY, CD4I ANTIBODY, ADCC, HIV-1 ENV, ANTI- HIV-1 ENV ANTIBODY JR4, IMMUNE SYSTEM
4tyu:A (GLN3) to (ALA64) HOMODIMERIC SINGLE DOMAIN ANTIBODY (SDAB) AGAINST STAPHYLOCOCCAL ENTEROTOXIN B (SEB) | SINGLE DOMAIN ANTIBODY, CAMELID, V-SET DOMAIN, AMYLOID LIKE
5h37:M (SER2) to (SER55) CRYO-EM STRUCTURE OF ZIKA VIRUS COMPLEXED WITH FAB C10 AT PH 8.0 | IGG NAG, VIRUS-IMMUNE SYSTEM COMPLEX
4u6g:B (GLU3) to (SER67) CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH A HYDROCARBON-STAPLED HIV-1 GP41 MPER PEPTIDE | 10E8 ANTIBODY, HIV-1, HYDROCARBON-STAPLE, GP41 MPER, IMMUNE SYSTEM
3p30:L (VAL3) to (SER56) CRYSTAL STRUCTURE OF THE CLUSTER II FAB 1281 IN COMPLEX WITH HIV-1 GP41 ECTODOMAIN | HIV, GP41, CLUSTER 2, FAB, 6-HELIX BUNDLE, IMMUNE SYSTEM
4ut6:L (LEU4) to (SER56) CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 B7 | VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE ANTIBODY NEUTRALIZATION, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4ut6:M (LEU4) to (SER56) CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 B7 | VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE ANTIBODY NEUTRALIZATION, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4eiz:D (GLN3) to (ALA61) STRUCTURE OF NB113 BOUND TO APODHFR | NADP BINDING, OXIDOREDUCTASE-IMMUNE SYSTEM COMPLEX
3qhz:L (PRO2) to (SER56) CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1 | IMMUNOGLOBULIN, IMMUNE RECOGNITION, INFLUENZA A HEMAGGLUTININ, IMMUNE SYSTEM
5kjr:L (GLN1) to (SER56) CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 W69A/S115W MUTANT AND M48U1. | HIV-1 GP120, CLADE A/E 93TH057, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX
5kw9:H (GLN3) to (ALA61) STRUCTURAL BASIS FOR NOROVIRUS NEUTRALIZATION BY A HBGA BLOCKING HUMAN IGA ANTIBODY | IGA, NOROVIRUS, NEUTRALISATION, FAB, ANTIBODY, ANTIVIRAL PROTEIN
5t33:L (TYR2) to (SER56) CRYSTAL STRUCTURE OF STRAIN-SPECIFIC GLYCAN-DEPENDENT CD4 BINDING SITE-DIRECTED NEUTRALIZING ANTIBODY CAP257-RH1, IN COMPLEX WITH HIV-1 STRAIN RHPA GP120 CORE WITH AN OLIGOMANNOSE N276 GLYCAN. | HIV, STRAIN-SPECIFIC, NEUTRALIZING ANTIBODY, CD4 BINDING SITE, N276 GLYCAN, GLYCAN-FREE V5, IMMUNE SYSTEM
5t3z:E (ALA3) to (SER56) 3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074 | HIV, N-LINKED GLYCOSYLATION, BROADLY NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1aqk:L (PCA1) to (SER58) THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR TETANUS TOXOID | HUMAN FAB, ANTI-TETANUS TOXOID, HIGH AFFINITY, CRYSTAL PACKING MOTIF, PROGRAMMING PROPENSITY TO CRYSTALLIZE, IMMUNOGLOBULIN
3fku:Y (GLN1) to (ALA61) CRYSTAL STRUCTURE OF INFLUENZA HEMAGGLUTININ (H5) IN COMPLEX WITH A BROADLY NEUTRALIZING ANTIBODY F10 | INFLUENZA, HEMAGGLUTININ, NEUTRALIZING ANTIBODY, SCFV, H5, F10, CELL MEMBRANE, ENVELOPE PROTEIN, FUSION PROTEIN, MEMBRANE, TRANSMEMBRANE, VIRION, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, LIPOPROTEIN, PALMITATE, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3fku:Z (VAL2) to (ALA61) CRYSTAL STRUCTURE OF INFLUENZA HEMAGGLUTININ (H5) IN COMPLEX WITH A BROADLY NEUTRALIZING ANTIBODY F10 | INFLUENZA, HEMAGGLUTININ, NEUTRALIZING ANTIBODY, SCFV, H5, F10, CELL MEMBRANE, ENVELOPE PROTEIN, FUSION PROTEIN, MEMBRANE, TRANSMEMBRANE, VIRION, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, LIPOPROTEIN, PALMITATE, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3fku:S (GLN1) to (ALA61) CRYSTAL STRUCTURE OF INFLUENZA HEMAGGLUTININ (H5) IN COMPLEX WITH A BROADLY NEUTRALIZING ANTIBODY F10 | INFLUENZA, HEMAGGLUTININ, NEUTRALIZING ANTIBODY, SCFV, H5, F10, CELL MEMBRANE, ENVELOPE PROTEIN, FUSION PROTEIN, MEMBRANE, TRANSMEMBRANE, VIRION, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, LIPOPROTEIN, PALMITATE, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3fku:T (GLN1) to (ALA61) CRYSTAL STRUCTURE OF INFLUENZA HEMAGGLUTININ (H5) IN COMPLEX WITH A BROADLY NEUTRALIZING ANTIBODY F10 | INFLUENZA, HEMAGGLUTININ, NEUTRALIZING ANTIBODY, SCFV, H5, F10, CELL MEMBRANE, ENVELOPE PROTEIN, FUSION PROTEIN, MEMBRANE, TRANSMEMBRANE, VIRION, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, LIPOPROTEIN, PALMITATE, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3fku:U (VAL2) to (ALA61) CRYSTAL STRUCTURE OF INFLUENZA HEMAGGLUTININ (H5) IN COMPLEX WITH A BROADLY NEUTRALIZING ANTIBODY F10 | INFLUENZA, HEMAGGLUTININ, NEUTRALIZING ANTIBODY, SCFV, H5, F10, CELL MEMBRANE, ENVELOPE PROTEIN, FUSION PROTEIN, MEMBRANE, TRANSMEMBRANE, VIRION, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, LIPOPROTEIN, PALMITATE, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1dcl:B (LEU4) to (SER58) MCG, A LAMBDA V TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN), CRYSTALLIZED FROM AMMONIUM SULFATE | IMMUNOGLOBULIN, BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES
4y5x:B (LEU4) to (SER57) DIABODY 305 COMPLEX WITH EPOR | DIABODY COMPLEX, RECEPTOR
4y5x:E (LEU4) to (SER57) DIABODY 305 COMPLEX WITH EPOR | DIABODY COMPLEX, RECEPTOR
4y5x:H (LEU4) to (SER57) DIABODY 305 COMPLEX WITH EPOR | DIABODY COMPLEX, RECEPTOR
1uwe:V (LEU4) to (ASN60) MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9 | ANTIBODY
4o5i:T (LEU4) to (SER67) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ | IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5cgy:D (VAL4) to (SER57) FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21 | ANTIBODY, FAB, IMMUNE SYSTEM
5cjs:L (ALA3) to (SER56) CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114 | HEMAGGLUTININ, TRIMER, INFLUENZA, IMMUNOGEN, MONOCLONAL, ANTIBODY, NEUTRALIZING, INFLUENZA VACCINE, GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1mcc:A (PRO1) to (SER69) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN, IMMUNE SYSTEM
3mlx:L (VAL3) to (SER56) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
4rav:D (LEU131) to (SER185) CRYSTAL STRUCTURE OF SCFVC4 IN COMPLEX WITH THE FIRST 17 AA OF HUNTINGTIN | IMMUNOGLOBULIN FOLD, IMMUNITY, 1-17 RESIDUES OF HUNTINGTIN, IMMUNE SYSTEM-APOPTOSIS COMPLEX
4ttd:L (VAL3) to (SER56) STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | IMMUNE SYSTEM, AFFINITY MATURATION
4d9l:N (LEU4) to (SER56) FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
4u7s:B (GLN3) to (ALA64) HOMODIMERIC SINGLE DOMAIN ANTIBODY (SDAB) AGAINST STAPHYLOCOCCAL ENTEROTOXIN B (SEB) CRYSTALLIZED FOR 5 MONTHS | BETA HELICAL, AMYLOID-LIKE, V-SET DOMAIN, SINGLE DOMAIN ANTIBODY
3qxw:A (GLN3) to (GLY63) FREE STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY | CAMELID SINGLE DOMAIN ANTIBODY, HEAVY CHAIN ONLY, VHH, ANTIBODY, ANTI-HAPTEN ANTIBODY, CDR, HAPTEN BINDING, SMALL MOLECULE SENSING, LIGAND BINDING, LOW MOLECULAR WEIGHT COMPOUND, METHOTREXATE, IMMUNE SYSTEM
3qxw:B (GLN3) to (GLY63) FREE STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY | CAMELID SINGLE DOMAIN ANTIBODY, HEAVY CHAIN ONLY, VHH, ANTIBODY, ANTI-HAPTEN ANTIBODY, CDR, HAPTEN BINDING, SMALL MOLECULE SENSING, LIGAND BINDING, LOW MOLECULAR WEIGHT COMPOUND, METHOTREXATE, IMMUNE SYSTEM